A phase II trial of 6-hydroxymethylacylfulvene (MGI-114, irofulven) in patients with advanced non-small cell cancer previously treated with chemotherapy
- Resource Type
- Journal
- Source
INVESTIGATIONAL NEW DRUGS ; FEB 2001, 19 1, p85-p88, 4p.- Subject
- Language
- English
- ISSN
- 01676997